Respected Sir/Madam, Please find attached the letter for your reference and record Thanks

Date: Nov 2th ,2026 The Manager, Lis(cid:415)ng department, BSE Limited, P.J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code:-539428 Security ID:-TEJNAKSH Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - International Recognition of Dr. Ashish V. Rawandale-Patil, Managing Director Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that Dr. Ashish V. Rawandale-Patil, Managing Director of Tejnaksh Healthcare Limited, has been selected as a Mentor for the Technology Innovation Program 2027 (ES-TIP 2027) of the Endourological Society, a globally recognized international organization in the field of urology. The Technology Innovation Program aims to support and mentor medical innovations and assist healthcare professionals in developing novel ideas for improving patient care, with promising innovations being considered for further development and commercialization. Dr.Ashish Rawandale-Patil has been selected as one of the mentors for the program and is the only urologist from outside the United States to join three other distinguished mentors from leading institutions in the United States. This recognition reflects his contribution to medical innovation and highlights India's growing presence on the global healthcare innovation platform. The Company believes that this prestigious international recognition enhances the reputation and visibility of Tejnaksh Healthcare Limited and showcases the global expertise and leadership associated with the Company. Kindly take the above information on record. Thanking you. Yours faithfully, For, Tejnaksh Healthcare Limited Dr. Ashish V. Rawandale Managing Director DIN:-02005733